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Abstract
Pigmentation evolved in ancestral humans to protect against toxic, ultraviolet B ir-
radiation, but the question remains: “what is being protected?” Because humans with 
dark pigmentation display a suite of superior epidermal functions in comparison with 
their more lightly pigmented counterparts, we hypothesized and provided evidence 
that dark pigmentation evolved in Africa to support cutaneous function. Because our 
prior clinical studies also showed that a restoration of a competent barrier dampens 
cutaneous inflammation, we hypothesized that resistance to inflammation could have 
provided pigmented hominins with yet another, important evolutionary benefit. We 
addressed this issue here in two closely related strains of hairless mice, endowed with 
either moderate (Skh2/J) or absent (Skh1) pigmentation. In these models, we showed 
that (a) pigmented mice display a markedly reduced propensity to develop inflamma-
tion after challenges with either a topical irritant or allergen in comparison with their 
nonpigmented counterparts; (b) visible and histologic evidence of inflammation was 
paralleled by reduced levels of pro‐inflammatory cytokines (i.e., IL‐1α and INFα); (c) 
because depigmentation of Skh2/J mouse skin enhanced both visible inflammation 
and pro‐inflammatory cytokine levels after comparable pro‐inflammatory challenges, 
the reduced propensity to develop inflammation was directly linked to the presence 
of pigmentation; and (d) furthermore, in accordance with our prior work showing that 
pigment production endows benefits by reducing the surface pH of skin, acidifica-
tion of albino (Skh1) mouse skin also protected against inflammation, and equalized 
cytokine levels to those found in pigmented skin. In summary, pigmentation yields 
a reduced propensity to develop inflammation, consistent with our hypothesis that 
dark pigmentation evolved in ancestral humans to provide a suite of barrier‐linked 
benefits that now include resistance to inflammation.
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1  | INTRODUC TION
It is generally acknowledged that two of the three unique features 
of human skin—widespread dispersion of sweat glands and shedding 
of their furry pélage—evolved to facilitate the dissipation of heat 
as ancestral Homo began to venture out onto open savannahs (rev. 
in Jablonski & Chaplin, 2017). The underlying epidermis of furred 
mammals is pale (with the exception of polar bears). Indeed, genetic 
studies have shown that the skin of ancestral humans only began 
to darken after Homo erectus shed his furry mantle over one million 
years ago. But the evolutionary “driver” of this third, unique feature 
of human skin—deep cutaneous pigmentation—is hotly debated. 
While there is wide agreement that dark pigmentation (DP) arose in 
response to the relentless assault of toxic ultraviolet (UV‐B) irradi-
ation at sub‐Saharan latitudes (Ibid.), the identity of the threatened 
structural or biochemical target is disputed. A still‐prevalent expla-
nation for the evolution of DP holds that it emerged to prevent the 
development of UV‐induced skin cancers (Brenner & Hearing, 2008; 
Lin & Fisher, 2007), a theory that has recently fallen out of favor, 
because: (a) neolithic humans remained dark after migrating into less 
UV‐B intense latitudes in south‐central Europe (Olalde et al., 2014); 
(b) despite the oft‐cited Loomis diagram (Loomis, 1967), the latitude‐
dependent loss of pigmentation did not occur except in Europeans 
of the far North; (c) the great majority of nonmelanoma skin cancers 
emerge long after peak reproductive years (Elias & Williams, 2013; 
Jablonski & Chaplin, 2017); and few fossils of ancestral humans were 
aged over 40 years (cited in Elias & Williams, 2015).
The current, prevailing paradigm holds that DP evolved to protect 
against congenital anomalies attributable to UV‐induced destruction 
of the photosensitive vitamin, folic acid (Chaplin & Jablonski, 2009; 
Jablonski & Chaplin, 2010, 2017). While in vitro irradiation photo-
degrades folic acid and its active metabolites (Fukuwatari, Fujita, & 
Shibata, 2009; Jones, Lucock, Veysey, & Beckett, 2018; Juzeniene, 
Thu Tam, Iani, & Moan, 2009; Off et al., 2005; Steindal, Tam, Lu, 
Juzeniene, & Moan, 2008), as well as inhibiting enzymes that are in-
volved in folate metabolism (Jones et al., 2018), a substantial body of 
evidence contradicts this putative relationship (rev in Elias & Williams, 
2015, 2018). Not only is the overall prevalence of congenital neuro-
anomalies very low (<1:2,000 births), but the great majority of them 
were also not severe enough to have compromised reproductive fit-
ness (Northrup & Volcik, 2000). Even more convincing are studies in 
patients receiving repeated, supraphysiologic doses of either incident 
UV‐B or UV‐A irradiation for the treatment of inflammatory skin dis-
orders. With one exception (El‐Saie, Rabie, Kamel, Seddeik, & Elsaie, 
2011), these studies have shown little or no decline in postirradiation 
levels of circulating folic acid (e.g., Cicarma et al., 2010; Gambichler, 
Bader, Sauermann, Altmeyer, & Hoffmann, 2001; Juzeniene, Stokke, 
Thune, & Moan, 2010). Moreover, though folic acid is sensitive to UV 
light in the “test tube” (Fukuwatari et al., 2009; Juzeniene, Thu Tam, 
Iani, & Moan, 2013), little incident UV‐B reaches the deeper layers of 
skin (Anderson & Parrish, 1981; Honigsmann, 2002), where this vita-
min circulates. Finally, dietary sources of folic acid have always been 
both readily and widely available (Shane, 2010). Thus, it seems unlikely 
that protection against UV‐induced, folic acid degradation “drove” the 
evolution of dark pigmentation (Northrup & Volcik, 2000; Rasmussen 
et al., 1998; Rayburn, Stanley, & Garrett, 1996).
Our prior studies of DP versus lightly pigmented (LP) humans 
suggest a third possible “driver” of epidermal pigmentation. Though 
several epidemiologic studies report a paradoxically greater, rather 
than a lesser propensity to develop inflammatory dermatoses in DP 
humans, these disorders also tend to be more severe in DP humans 
(Abuabara et al., 2019; DeFelice & Yousef, 2008; Moore et al., 2004; 
Vachiramon, Tey, Thompson, & Yosipovitch, 2012; Wegienka et al., 
2012; Williams et al., 1995). To address this apparent paradox, we as-
sessed whether DP bestows yet another, barrier‐related advantage 
by increasing inflammatory thresholds, potentially protecting ances-
tral humans from a variety of potentially harmful, pro‐inflammatory 
insults. Yet, DP humans demonstrate both superior epidermal per-
meability barrier function and stratum corneum cohesion in com-
parison with LP subjects (Gunathilake et al., 2009; Reed, Ghadially, 
& Elias, 1995), independent of race, ethnicity, latitude of residence, 
gender, or occupation. Because “resetting” the surface pH of LP hu-
mans downward to levels found in DP subjects bestowed them with 
optimal cutaneous function (Gunathilake et al., 2009), the benefits 
of DP can be attributed to the reduced surface pH of DP individuals.
Our results in closely related mouse strains with divergent pig-
mentation show that pigmented mouse skin resists both irritant and 
allergic insults better than the skin of albino mice, and that this resis-
tance can be attributed to both the presence of cutaneous pigmen-
tation and the impact of the lower pH endowed by pigmentation 
(Man et al., 2014). Together, these results provide further support 
for the hypothesis that deep pigmentation evolved in ancestral hu-
mans (Elias, Menon, Wetzel, & Williams, 2009, 2010) in order to sup-
port epidermal structure and function (Elias & Williams, 2013).
Because a reduced skin surface pH offers many advantages for epi-
dermal structure and function (rev. in Elias, 2017), we hypothesized that 
DP initially evolved to support cutaneous structure and function in the 
recently denuded skin of ancestral humans (Elias et al., 2009, 2010). As 
they ventured out onto open savannahs (Elias & Williams, 2013), toxic 
doses of UV‐B, which compromise the permeability barrier (Biniek, 
Levi, & Dauskardt, 2012; Haratake et al., 1997; Holleran et al., 1997), 
coupled with the extreme xeric stress of this region due to both ep-
ochal drying (e.g., Blome, Cohen, Tryon, Brooks, & Russell, 2012) and 
repeated megadroughts (e.g., DeMenocal, 2004) would have inevitably 
placed further stress on the epidermis of denuded skin. In this context, 
the evolution of DP would have provided important benefits: first and 
foremost, it would have “reset” the threshold for UV‐B‐induced toxicity, 
while simultaneously providing the additional, substantial benefits of 
“suberythemogenic” UV‐B. In contrast to the harmful impact of ery-
themogenic UV‐B, suberythemogenic doses enhance (a) permeability 
barrier function, minimizing losses of internal water into the desiccating 
milieu of sub‐Saharan Africa; and (b) innate immunity against microbial 
pathogens (Hong et al., 2008). Finally, in pertinent clinical studies, we 
showed that restoration of normal barrier function in inflamed human 
and murine skin provides an additional benefit—it reduces the severity 
of inflammation (rev in Elias, 2017; Elias, Wakefield, & Man, 2018). By 
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comparing the propensity to develop inflammation in two genetically 
related mouse strains that differ in the extent of their pigmentation, we 
addressed the clinical paradox of more frequent severe inflammatory 
dermatoses in DP humans.
2  | METHODS AND MATERIAL S
2.1 | Animals and materials
Female hairless, nonpigmented mice (Crl:Skh1‐ Hrhr/Hrhr), referred 
herein as Skh1 mice, were obtained from Charles River Laboratories, 
while pigmented (Skh2/J‐ Hrhr/Hrhr) hairless mice (Skh2/J) were from 
Jackson Laboratory. The latter mice display diffuse pigmentation 
(Man et al., 2014), which is further accentuated in the skin of their 
ears. All mice were fed a standard mouse diet (Ralston‐Purina Co), 
had access to tap water ad libitum, and were studied between 6 and 
8 weeks of age. Mice were housed in a temperature‐ and humidity‐
controlled, SPF facility. Affinity‐purified, rabbit anti‐mouse antibod-
ies to TNFα, IL‐1α, and IL‐1β were purchased from Abcam. Methanol, 
ethanol, propylene glycol (PG), 4‐ethoxymethylene‐2‐phenyl‐2‐oxa-
zolin‐5‐one (Ox), and 12‐O‐tetradecanoylphorbol 13‐acetate (TPA), 
hydroquinone (HQ), and lactobionic acid (LBA) were from Sigma. 
Fontana–Masson (melanin staining kit) was from Abcam. Samples 
for melanin staining were fixed in 10% buffered formalin, embedded 
in paraffin, and routinely processed. Five‐micrometer sections were 
used for the staining, using the Fontana–Masson method, following 
the protocol provided in the Fontana–Masson Kit (Abcam).
2.2 | Experimental procedures
2.2.1 | Irritant contact dermatitis model
Initially, for depigmentation, 4% hydroquinone (HQ), dissolved in 
absolute ethanol, was applied twice daily onto the dorsal skin of de-
pigmented Skh2/J mice for ten days. The phorbol ester, 12‐O‐tet-
radecanoylphorbol‐13‐acetate (TPA) was utilized as the irritant to 
induce Irritant contact dermatitis (ICD) in pigmented and nonpig-
mented skin. Female hairless mice (Skh1 and Skh2/J) were divided 
into five groups: (a) control SKH1; (b) TPA‐treated Skh1; (c) control 
Skh2/J; (d) TPA‐treated Skh2/J; and (e) TPA‐treated, depigmented 
Skh2/J groups. 0.001% TPA (in absolute ethanol) was applied once 
or twice daily to the dorsal skin for 10 days. Twenty‐four hours after 
the last challenge, transepidermal water loss (TEWL) and stratum 
corneum (SC) hydration were assessed with respective probes con-
nected to a Tewameter (MPA5, Courage & Khazaka), as described 
previously (Hatano et al., 2011; Man et al., 2008). Skin samples for 
real‐time PCR (rtPCR) were taken immediately after the last func-
tional determinations, as below (Man et al., 2008).
2.2.2 | Atopic dermatitis (AD) model
4‐Ethoxymethylene‐2‐phenyl‐2‐oxazolin‐5‐one (oxazolone, Ox) was 
utilized to induce AD in pigmented and nonpigmented mice, divided 
into the same five cohorts described above. Female hairless mice 
(Skh1 and Skh2/J) were first sensitized with 3% Ox (in absolute 
ethanol), applied topically to dorsal skin and flanks. After one week, 
0.01% Ox was applied once daily to the dorsal and flank skin for 
21 days, producing the AD model (Man et al., 2008).
2.3 | Depigmentation/acidification in animal models
2.3.1 | Irritant contact dermatitis model
Female Skh2/J hairless mice were divided into the four cohorts: 
control Skh2/J, TPA‐treated Skh2/J, TPA‐treated, depigmented 
Skh2/J, and TPA‐treated depigmented/acidified Skh2/J group. 4% 
hydroquinone (HQ), dissolved in absolute ethanol, was applied twice 
daily onto the dorsal skin of depigmented Skh2/J mice for ten days. 
0.005% TPA was then applied once daily to dorsal skin and flanks 
for up to 21 days. The length of TPA treatments again depended 
upon the appearance of visible inflammation in the Skh2/J mice. 
During the 21 days of TPA challenges, HQ was applied twice daily 
to the dorsal skin and flanks of depigmented Skh2/J mice, with the 
first application at least 1 hr after the prior daily TPA challenge. 10% 
lactobionic acid (LBA) (dissolved in PG:water:ethanol [2:2:6 vols]) 
was applied daily after HQ treatment of one depigmented group. 
24 hr after the last challenge, skin surface pH, melanin indices and 
the extent of erythema were assessed with a pH900 pH probe and 
MEXAMETER® 18 probe, respectively, connected to the MPA5, as 
above. Thereafter, skin samples were obtained for rtPCR (see below).
2.3.2 | Atopic dermatitis (AD) model
Skh2/J mice were divided into the same 4 groups as above. Female 
Skh2/J hairless mice were first sensitized with 3% Ox, applied topi-
cally to both dorsal and flank skin. 4% Hydroquinone (HQ) dissolved in 
absolute ethanol was applied twice daily to the dorsal skin and flanks 
of one of the depigmented SKH2/J group for the following week, fol-
lowing which, 0.01%~0.05% Ox was applied once daily to the dorsal 
skin and flanks for 17 days. The concentration of Ox applied depended 
upon the extent of visible dermatitis in Skh2/J mice with AD‐like der-
matitis. During the 17 days of Ox challenges, hydroquinone (HQ) was 
applied twice daily, with the first application at least one hour after 
the prior Ox challenge. In one cohort, 10% lactobionic acid (LBA; dis-
solved in PG:water:ethanol [2:2:6 vols]) was applied daily after the 
prior HQ treatment and 24 hr after the last Ox challenge. Then, mela-
nin and erythema indices, as well as skin surface pH, were assessed as 
above, and skin samples were obtained for rtPCR (see below).
2.4 | Quantitative PCR for mRNA expression
Total epidermal RNA was isolated from sheets of hairless mouse 
epidermis (Proksch, Elias, & Feingold, 1991), using TRIzol Reagent 
(Sigma‐Aldrich; catalog number T9424), according to the manufac-
turer's directions. First‐strand cDNA was synthesized from 1 μg 
of total RNA with the Transcriptor First‐Strand cDNA Synthesis 
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Kit (Roche, catalog number 04897030001) in a total volume of 
20 μl. Real‐time PCR utilized 60 ng of reversed‐transcribed cDNA, 
300 nm each of forward and reverse primers, and 10 μl of SYBR® 
Green PCR Master Mix (Thermo Fisher Scientific) in a final volume 
of 20 μl in 96‐well plates using the new Step One(TM) Real‐Time PCR 
System. Quantitation was performed by the comparative threshold 
cycle method with mouse glyceraldehyde‐3‐phosphate dehydro-
genase used for normalization. The primer sequences for tumor 
necrosis factor‐α (TNF‐α) were 5′‐ TTGAGATCCATGCCGTTG‐3′ 
(forward) and 5′‐CTGTAGCCCACGTCGTAGC‐3′ (re-
verse). The primer sequences for interleukin 1α (IL‐1α) 
were 5′‐ TGGGTATCTCAGGCATCTCC‐3′ (forward) and 5′‐ 
ATCAGTACCTCACGGCTGCT‐3′ (reverse). The primer sequences 
for interleukin 1β (IL‐1β) were 5′‐ TCTTCTTTGGGTATTGCTTGG‐3′ 
(forward) and 5′‐ TGTAATGAAAGACGGCACACC‐3′ (reverse). The 
primer sequences for mouse glyceraldehyde‐3‐phosphate dehydro-
genase (GAPDH) were 5′‐ CTGCTTCACCACCTTCTTGA‐3′ (forward) 
and 5′‐ AAGGTCATCCCAGAGCTGAA‐3′ (reverse). For all PCR stud-
ies, all samples were run in triplicate, and expression of mRNAs was 
normalized to GAPDH mRNA, and the expression of mRNAs relative 
to mRNA levels in the epidermis of control mice was calculated and 
expressed as percent of controls (setting controls at 100%).
2.5 | Statistical analyses
Data are expressed as the means ± SEM. Unpaired two‐tailed 
Student's t test with Welch's correction was used to determine 
significant differences when two groups were compared, and a 
one‐way ANOVA with a post‐Tukey test or Dunnett postcorrection 
was used to determine significant differences when three or more 
groups were compared. Further details about statistical methods 
can be found in the figure legends.
3  | RESULTS
3.1 | Less Severe ICD and AD in Pigmented than in 
Albino Mice
Though cutaneous pigmentation appears most prominent in the ear 
skin of Skh2/J mice, our prior studies showed that the entire skin sur-
face of Skh2/J epidermis is also uniformly populated by a mat of mel-
anocytes, with melanin production evident histologically (Man et al., 
2014). In contrast, the skin of Skh1 mice, though populated by mel-
anoblasts, is completely devoid of functional melanocytes and mela-
nin (Ibid.). Hence, we initially compared the severity of inflammatory 
responses on the flanks of pigmented (Skh2/J) versus nonpigmented 
(Skh1) hairless mice. Visible inflammation was markedly more severe 
in Skh1 than in Skh2/J mice after comparable challenges with either 
the phorbol ester, TPA (irritant contact dermatitis [ICD] model; Sheu 
et al., 2002), or the universal hapten, oxazolone (Ox), which produces 
an atopic dermatitis (AD)‐like phenotype in mice (Man et al., 2008; 
Figure 1a and b). Specifically, clinical features of inflammation (ery-
thema and scaling) were much less apparent in both TPA‐treated and 
Ox‐challenged Skh2/J mice than in comparably challenged Skh1 mice. 
F I G U R E  1   Pigmentation increases 
inflammatory thresholds. Irritant 
(ICD) and atopic dermatitis (AD)‐
like inflammation were induced by 
repeated topical applications of TPA 
and oxazolone (Ox), respectively, as 
detailed in Methods. Figure 1a depicts 
mice treated with TPA, while Figure 1b 
shows mice treated repeatedly with Ox. 
Figure 1c & d presents changes in TEWL 
levels and stratum corneum hydration, 
respectively, in pigmented (Skh2/J) versus 
nonpigmented (Skh1) mice. Unpaired 
two‐tailed t test was used to determine 
the significance between the two groups. 
p values (Skh1 vs. Skh2 mice) are indicated 
as “a” and “b” in Figure 1c and d. N = 10 
for mice treated with TPA; N = 11 for Skh1 
mice treated with Ox; N = 16 for Skh2/J 
mice treated with Ox
(a)
(c) (d)
(b)
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Finally, these differences in the extent of inflammation were paralleled 
by differences in epidermal function that persist, even in the aftermath 
of pro‐inflammatory challenges (Figure 1c and d).
3.2 | More Severe ICD and AD Following 
Depigmentation of Skh2/J Mice
To determine whether the decreased inflammation in Skh2/J mice 
could be attributed to the presence of cutaneous pigmentation, we 
next eliminated melanin on the flanks of Skh2/J mice through re-
peated, topical applications of hydroquinone (HQ), prior to the in-
duction of either ICD or AD, as above. As previously reported (Man 
et al., 2014), pigmented, control mice treated with HQ lost all evi-
dence of pigment (see also Figure S1). While topical HQ can occa-
sionally be irritating to human skin, HQ applications to Skh2/J mouse 
skin provoked neither cutaneous inflammation nor alterations in epi-
dermal function (Figure S2). Macroscopic and quantitative evidence 
of both TPA‐ and hapten‐induced inflammation became much more 
apparent in Skh2/J mice that had been previously depigmented, be-
coming comparable to the levels of inflammation found in similarly 
treated Skh1 mice (Figures 2a, 3a, 4a). Together, these results dem-
onstrate that the differences in inflammatory thresholds in Skh2/J 
versus Skh1 mice can be attributed to the presence or absence of 
cutaneous pigmentation.
3.3 | Changes in Epidermal Cytokine Levels after 
Irritant or Hapten Challenges Are Pigment‐Dependent
Challenges with topical irritants or haptens stimulate the produc-
tion of epidermal pro‐inflammatory cytokines, including TNFα 
F I G U R E  2   Depigmentation Decreases Inflammatory Thresholds in Pigmented Mice with Irritant Contact Dermatitis (ICD). Figure 2a 
displays visible changes in inflammation in depigmented Skh2/J in comparison with Skh1 mice. Figure 2b shows epidermal melanin content in 
TPA‐treated Skh2/J mice, with or without prior depigmentation with topical hydroquinone (HQ). Data are expressed as % of normal Skh2/J 
mice (setting normal control as 100%, shown in dotted line). Figure 2c compares levels of epidermal TNFα and IL‐1α protein before and after 
depigmentation with HQ. Expression levels were normalized to respective normal controls, setting normal controls as 1. Data are expressed 
as fold‐changes from respective normal controls (shown in dotted lines). Figure 2d exhibits changes in epidermal TNFα and IL‐1α mRNA 
levels after depigmentation. Data are expressed as % of normal controls (shown in dotted lines). One‐way ANOVA with Tukey's multiple 
comparison test was used to determine the statistical significances among groups. For Figure 2b, unpaired two‐tailed t test was also used to 
determine the significance between the two groups. p, F, and t values are indicated in the figures. N = 5 for all groups
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and IL‐1α (Fowler et al., 2003; Funding et al., 2009; Lessard et 
al., 2013; Sheu et al., 2002), thereby serving as surrogate indi-
cators of cutaneous inflammation. Although there were no dif-
ferences in the baseline levels of multiple epidermal cytokines in 
pigmented versus nonpigmented mice (Figure S3), mRNA levels 
of both epidermal TNFα and IL‐1α increased markedly in Skh1 in 
comparison with Skh2/J mice after comparable irritant or hap-
ten challenges (Figures 2c,d and 3c,d). Yet, after Skh2/J mice had 
been previously depigmented with HQ (Figure 2b and 3b) and 
then challenged with either the irritant or hapten, epidermal cy-
tokine mRNA levels became comparable to those encountered 
in the epidermis of similarly challenged Skh1 mice (Figure 2c,d 
and 3c,d). Pertinently and consistent with the lack of evidence 
of inflammation in HQ‐treated skin, topical applications of HQ 
alone did not stimulate cytokine production (Figure S2). Together, 
these results demonstrate that the decreased susceptibility of 
pigmented murine skin to inflammatory stimuli can be attributed 
to the presence of epidermal pigmentation.
3.4 | Decreased Inflammation in Pigmented Mice 
Can Be Attributed to a Pigment‐dependent Decline in 
Surface pH
Our prior studies showed that the lower pH of DP human and pig-
mented mouse skin accounts for their superior function, because 
lowering the surface pH of lightly pigmented humans and mice “reset” 
these functions to levels comparable to pigmented skin (Gunathilake et 
al., 2009; Man et al., 2014). Hence, we next assessed whether the lower 
surface pH of DP skin protects against the development of inflamma-
tion. Pertinently, while the baseline surface pH of Skh2/J mouse skin 
was again lower than that of Skh1 mice (Man et al., 2014), the pH of 
Skh2/J mice increased in parallel with the emergence of inflammation 
in depigmented animals (Figure 4b and 5b). Though prior HQ‐induced 
depigmentation of Skh2/J mice again predisposed to greater inflam-
mation and cytokine production after either irritant (Figure 4a,c,d) or 
hapten challenges (Figure 5a,c,d), topical applications of a nonirritat-
ing, acidifying agent, lactobionic acid (LBA) (Hachem et al., 2003, 2010) 
F I G U R E  3   Depigmentation Decreases Inflammatory Thresholds in Pigmented Mice with Atopic Dermatitis (AD). Figure 3a displays 
macroscopic changes in depigmented Skh2/J mice after hapten (Ox) challenges. Figure 3b shows differences in epidermal melanin content 
in oxazolone (Ox)‐treated Skh2/J mice, with or without topical applications of hydroquinone (HQ). Data are expressed as % of normal 
Skh2/J mice (setting normal control as 100%, shown in dotted line). Figure 3c displays changes in epidermal TNFα and IL‐1α protein levels. 
Expression levels were normalized to respective normal controls, setting normal controls as 1. Data are expressed as fold‐changes from 
respective normal controls (shown in dotted lines). Figure 3d exhibits changes in epidermal TNFα and IL‐1α mRNA levels. Data are expressed 
as % of normal controls (shown in dotted lines). One‐way ANOVA with Tukey's multiple comparison test was used to determine the 
statistical significances among groups. For Figure 3b, unpaired two‐tailed t test was also used to determine the significance between the two 
groups. p, F, and t values are indicated in the figures. N = 6 for all groups
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prevented the subsequent development of inflammation in previously 
depigmented Skh2/J mouse skin (Figures 4a and 5a). These pH‐de-
pendent changes in inflammatory thresholds were paralleled again 
by differences in epidermal pro‐inflammatory cytokine production 
(Figures 4c,d and 5c,d). Similar results were obtained in both the ir-
ritant contact dermatitis and atopic dermatitis models of acidified Skh1 
mouse skin (Figure S4). Together, these results indicate that the anti‐in-
flammatory benefits of cutaneous pigmentation can be further attrib-
uted to the endowment of pigmented skin with a reduced surface pH.
4  | DISCUSSION
Shortly after ancestral humans shed their furry mantles and ex-
panded the density of their sweat glands to allow more efficient 
dissipation of heat, their epidermis became deeply pigmented to pro-
tect the skin from UV‐B‐induced toxicity. Yet, whether this increase 
in cutaneous pigmentation evolved primarily to protect against folic 
acid degradation (Chaplin & Jablonski, 2009); DNA damage leading 
to cutaneous malignancies (Brenner & Hearing, 2008); and/or en-
hanced permeability barrier function (Elias et al., 2009, 2010) is hotly 
debated. Because our earlier studies had shown that DP humans 
display superior epidermal barrier function in comparison with their 
LP counterparts, independent of race, ethnicity, geography, gender, 
or occupation (Gunathilake et al., 2009; Reed et al., 1995), we have 
championed the last possibility (Elias & Williams, 2013).
Sub‐Saharan Africa is not only bathed in erythemogenic UV‐B 
light that is toxic to the skin barrier (Biniek et al., 2012; Elias & 
Williams, 2013; Haratake et al., 1997), it also was exposed to very 
low, ambient humidities during the millennia when ancestral hu-
mans first became pigmented (Blome et al., 2012; DeMenocal, 
1995). Steepening the gradient for transcutaneous water loss in this 
xeric environment doubtlessly further challenged the skin barrier. 
Moreover, DP humans, residing at tropical latitudes, also resist the 
high densities of microbial pathogens that they typically encounter 
(Mackintosh, 2001), in part due to differences in their skin surface 
pH (Gunathilake et al., 2009). Notably, microbial pathogens, such 
as e S. aureus and S. pyrogenes, proliferate avidly at a higher pH, 
F I G U R E  4   Acidification of Stratum Corneum Increases Inflammatory Thresholds in Depigmented Skh2/J Mice with Irritant Contact 
Dermatitis (ICD). Figure 4a displays visible changes in inflammation in Skh2/J mice after depigmentation ± acidification with lactobionic acid 
(LBA). Figure 4b shows differences in skin surface pH after various treatments. Figure 4c displays changes in levels of epidermal TNFα and 
IL‐1α mRNA levels after depigmentation ± acidification with LBA. Data are expressed as % of control Skh2/J mice, setting controls as 100% 
shown in dotted line. Figure 4d compares levels of epidermal TNFα and IL‐1α protein after various treatments. Data are expressed as fold‐
changes from untreated Skh2/J mice, setting controls as 1 shown in dotted line. One‐way ANOVA with Tukey's multiple comparison test was 
used to determine the statistical significances among groups. p, F, and t values are indicated in the figures. N = 5 for all groups
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but poorly at a reduced pH (Elias, 2007; Korting, Hubner, Greiner, 
Hamm, & Braun‐Falco, 1990). The salubrious benefits of DP for ad-
ditional epidermal functions can be further attributed to the reduced 
surface pH of pigmented skin (Elias, 2017), because exogenous acid-
ification of LP humans and nonpigmented mice “resets” these func-
tions (Gunathilake et al., 2009; Man et al., 2014).
Further studies in closely related strains of pigmented (Skh2/J) 
versus nonpigmented, albino (Skh1), hairless mice shed further light 
on the mechanisms whereby pigmentation‐induced reductions in 
skin surface pH are beneficial. As with LP humans, albino mice dis-
played functional deficits that were comparable to their LP human 
counterparts; and as in LP humans, lowering the surface pH of albino 
mice again optimized their cutaneous function (Man et al., 2014). The 
basis for the superior function of pigmented skin in these mice could 
be linked to the transfer of melanin granules of different sizes from 
melanocytes to keratinocytes. These granules are much larger in DP 
humans and mice than are the “crumbly” granules that are delivered 
to keratinocytes in LP human and mouse skin (Jimbow, Quevedo, 
Fitzpatrick, & Szabo, 1976; Szabo, Gerald, Pathak, & Fitzpatrick, 
1969). Once inside keratinocytes, all melanin granules, regardless of 
size, are captured within acidic phagolysosomes (Ando et al., 2012; 
Boissy, 2003). Then, whereas the smaller, “crumbly” granules of LP 
humans and animals are rapidly degraded, the larger granules of DP 
humans and pigmented mice instead persist high into the epidermis 
(Jimbow et al., 1976), where encircling phagolysosomes eventually 
release their cargo of melanin granules and protons (Man et al., 
2014).
Hence, we proposed that the aggregate functional stressors that 
were prevalent in Africa during the evolution of Homo sapiens could 
have further selected for the initial evolution and subsequent per-
sistence of dense epidermal pigmentation in ancestral humans (Elias 
& Williams, 2013, 2016). Despite the substantial metabolic costs of 
pigment production, this trait has persisted, likely because of the 
multiple benefits of dark pigmentation for cutaneous function (see 
below).
In these studies, we explored the merits of clinical studies, 
which have suggested that DP humans display both a greater 
propensity and a reduced threshold to develop inflammatory der-
matoses. We showed first that the extent of inflammation is reg-
ulated by the presence or absence of pigmentation; and further, 
F I G U R E  5   Acidification of Stratum Corneum Increases Inflammatory Thresholds in Depigmented Skh2/J Mice with Atopic Dermatitis 
(AD). Figure 5a displays visible changes in Skh2/J mice after treatments as in Figure 4, plus repeated hapten (Ox) applications Figure 5b 
shows differences in skin surface pH. Figure 5c displays differences in epidermal TNFα and IL‐1α mRNA levels. Data are expressed as % of 
control Skh2/J mice, setting controls as 100% shown in dotted line. Figure 5d exhibits changes in epidermal TNFα and IL‐1α protein levels. 
Data are expressed as fold‐changes for normal Skh2/J mice, setting controls as 1 shown in dotted line. One‐way ANOVA with Tukey's 
multiple comparison test was used to determine the statistical significances among groups. p, F, and t values are indicated in the figures. 
N = 7 for all groups, except for Skh2/J + Ox +Veh (N = 6)
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that the extent of inflammation is linked to the role of dark pig-
mentation in reducing the pH of the outer epidermis (Gunathilake 
et al., 2009; Man et al., 2014). These observations illuminate the 
key role of surface pH as a master regulator of permeability bar-
rier homeostasis, stratum corneum integrity, and antimicrobial de-
fense, a suite of benefits to which cutaneous inflammation now 
can be added. Although not yet assessed, it remains possible that 
changes in less metabolically expensive acidifying mechanisms; 
for example, the sodium proton transporter, NHE1, and/or one or 
more secretory phospholipases could contribute to strain‐specific 
differences in surface acidification. In further mechanistic stud-
ies, we have shown that major benefits of a low surface pH are 
(a) deactivation of pro‐inflammatory serine proteases (kallikreins), 
which damage epidermal structure and function (Elias, 2017; Jang 
et al., 2016; Voegeli et al., 2009); and 2) while simultaneous acti-
vation of two, beneficial ceramide‐generating enzymes (Uchida et 
al., 2000).
Our results must be tempered by two facts: (a) mice are distant 
relatives of humans, although mutant and genetically engineered 
mouse models have provided a remarkable array of insights about 
organ function in normal humans; and (b) although it is indisputable 
that innate and adaptive immune components of the inflammatory 
response are operative in both species, their details could differ. 
Nonetheless, we deployed these murine models to gain insights into 
the role of pigmentation in epidermal function. Despite the fact that 
the extent of inflammation can be difficult to assess in darkly pig-
mented skin, our results were unambiguous. Skh2/J mice display a 
broad dispersion of pigmentation across their rather pale‐appearing 
truncal skin (Man et al., 2014), allowing ready comparisons of the 
extent of inflammation. By multiple macroscopic, functional, and 
molecular parameters, Skh2/J skin displayed a markedly reduced 
propensity to develop inflammation in comparison with their pale‐
skinned (Skh1) counterparts. Indeed, our observations of differences 
in visible inflammation were inevitably paralleled by changes in der-
mal inflammation and levels of pro‐inflammatory cytokines.
The broad suite of functional benefits that are attributable to DP 
call into question the widely held belief that DP humans are more sus-
ceptible to inflammatory dermatoses (Abuabara et al., 2019; DeFelice 
& Yousef, 2008; Moore et al., 2004; Vachiramon et al., 2012; Williams 
et al., 1995). These studies raise the possibility that such reported 
differences in prevalence and severity could instead reflect sociocul-
tural or environmental conditions, including increased exposure to 
pathogens and allergens (Wegienka et al., 2012; Williams et al., 1995). 
Moreover, such crowded living conditions, often amplified by sur-
rounding, tall structures that block sunlight, reduce exposure to the 
salubrious benefits of suberythemogenic UV‐B (Thyssen, Zirwas, & 
Elias, 2015). Though the adverse impact of pigmentation in the above‐
cited clinical studies likely reflects one or more of these factors, addi-
tional studies are needed to assess whether such sociocultural and/or 
environmental disadvantages can account for the clinical disparities 
observed in prior epidemiologic studies.
In summary, while studies in mice may not always reflect sim-
ilar propensities in humans, our results suggest that resistance to 
inflammation can now be added to the growing list of ways in which 
dark pigmentation likely evolved to support cutaneous function in 
ancestral humans.
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